PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $127,000 | -96.7% | 15,896 | -96.5% | 0.03% | -93.7% |
| Q3 2021 | $3,793,000 | +24.2% | 453,182 | 0.0% | 0.41% | +50.0% |
| Q2 2021 | $3,054,000 | +1.9% | 453,182 | 0.0% | 0.27% | +19.1% |
| Q1 2021 | $2,996,000 | +57.4% | 453,182 | 0.0% | 0.23% | +56.5% |
| Q4 2020 | $1,903,000 | -30.9% | 453,182 | 0.0% | 0.15% | -52.6% |
| Q2 2020 | $2,755,000 | +12.1% | 453,182 | +1.2% | 0.31% | -34.0% |
| Q1 2020 | $2,458,000 | -44.7% | 447,657 | -0.3% | 0.47% | -70.1% |
| Q4 2019 | $4,448,000 | +65.8% | 448,880 | -3.6% | 1.57% | -6.5% |
| Q3 2019 | $2,682,000 | -36.7% | 465,580 | 0.0% | 1.68% | +10.9% |
| Q2 2019 | $4,237,000 | +379.8% | 465,580 | +631.1% | 1.52% | +791.8% |
| Q1 2019 | $883,000 | – | 63,680 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |